Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Observational × Hepatobiliary Cancers × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 417 Neoplasms 291 Carcinoma, Non-Small-Cell Lung 249 Prostatic Neoplasms 194 Colorectal Neoplasms 186 Lung Neoplasms 155 Multiple Myeloma 110 Melanoma 96 Carcinoma, Renal Cell 96 Ovarian Neoplasms 86 Carcinoma, Hepatocellular 64 Neoplasm Metastasis 62 Urinary Bladder Neoplasms 59 Pancreatic Neoplasms 59 Leukemia, Lymphocytic, Chronic, B-Cell 59 Stomach Neoplasms 56 Colonic Neoplasms 48 Leukemia, Myeloid, Acute 47 Uterine Cervical Neoplasms 43 Recurrence 43 Lymphoma, Follicular 43 Liver Neoplasms 40 Lymphoma 36 Lymphoma, Large B-Cell, Diffuse 33 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33 Esophageal Neoplasms 33 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Hematologic Neoplasms 31 Papillomavirus Infections 30 Kidney Neoplasms 29

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06252753 2025-12-26

LIVER-R

AstraZeneca

Gastrointestinal

Hepatobiliary Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡